| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 12/27/2002 | CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2448298A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | CA2446963A1 Quinazolinediones as antibacterial agents |
| 12/27/2002 | CA2439060A1 Emissive multichromophoric systems |
| 12/26/2002 | US20020198380 Reacting tetrachloropyrimido(5,4-d)pyrimidine with amine compound; reducing to form 4,6-diaminopyrimido(5,4-d)pyrimidine compound |
| 12/26/2002 | US20020198379 Active compound from a sponge |
| 12/26/2002 | US20020198377 For improving perception, concentration power, learning power and/ or memory power |
| 12/26/2002 | US20020198232 4-substituted quinoline derivatives |
| 12/26/2002 | US20020198223 Pharmaceutically active compounds |
| 12/26/2002 | US20020198222 Use of triazolopyrimidine derivatives as microbicides |
| 12/26/2002 | US20020198221 For use as sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent |
| 12/26/2002 | US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 12/26/2002 | US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 12/26/2002 | US20020198196 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 12/26/2002 | US20020198191 Cyclohexylphenyl vasopressin agonists |
| 12/26/2002 | US20020198190 Tetracyclic 1,2,3,4,5,6- hexahydroazepino-(4,5-b)indole derivatives having a ring connecting position 6 (N-6) and position 7 (C-7); treating or preventing a disease or disorder of the central nervous system in a mammal |
| 12/25/2002 | CN1387531A Pyrazolo [4,3-d] pyrimidine derivs. |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/24/2002 | US6498251 Tetrahydrobenzindole derivatives |
| 12/24/2002 | US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis |
| 12/24/2002 | US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/24/2002 | US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis |
| 12/24/2002 | CA2131019C Nitrosation process |
| 12/19/2002 | WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 12/19/2002 | WO2002100864A1 Pyrazolopyrazine compound and pharmaceutical use thereof |
| 12/19/2002 | WO2002100863A1 Corticotropin releasing factor antagonists |
| 12/19/2002 | WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 12/19/2002 | WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 12/19/2002 | WO2002100828A2 Process for the production of zaleplon |
| 12/19/2002 | WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs |
| 12/19/2002 | WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | WO2002100354A2 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 12/19/2002 | WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors |
| 12/19/2002 | WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 12/19/2002 | WO2002062797A3 Pharmaceutical uses and synthesis of diketopiperazines |
| 12/19/2002 | WO2002060894A3 Sulfonamide lactam inhibitors of factor xa |
| 12/19/2002 | WO2000058303A9 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands |
| 12/19/2002 | US20020193608 For preparing and using libraries of compounds as well as individual compounds of the libraries; for screening compounds for combinatorial chemistry |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/19/2002 | US20020193595 Agonists of the melanocortin-4 receptor ("MC-4r"); useful treating obesity and type 2 diabetes |
| 12/19/2002 | US20020193399 N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| 12/19/2002 | US20020193388 Pharmaceutically active compounds |
| 12/19/2002 | US20020193385 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 12/19/2002 | US20020193378 Usable as tranquillisers and hypnotics |
| 12/19/2002 | US20020193376 Administering compounds containing fused, 6-, 5-membered bicyclic heteroaromatic rings containing nitrogen as one of the two bridging atoms for decreasing intraocular pressure in an animals including humans |
| 12/19/2002 | US20020193364 For therapy of central nervous system (CNS) diseases |
| 12/19/2002 | US20020193239 For use as catalysts in epoxidation of olefins, for oxidation of alcohols, oxidation of organic thiols; hydroxylation of aromatic compounds; ammoximation of ketones |
| 12/19/2002 | CA2450384A1 Process for the production of zaleplon |
| 12/19/2002 | CA2449544A1 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs |
| 12/19/2002 | CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/18/2002 | EP1266899A2 Rapamycin hdroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 12/18/2002 | EP1265901A2 Process for the preparation of midazolam |
| 12/18/2002 | EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 12/18/2002 | EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 12/18/2002 | EP1265897A1 Non-amidine containing protease inhibitors |
| 12/18/2002 | EP0725783B1 2-(pyrazol-3-yl)carbapenem derivatives |
| 12/18/2002 | CN1385430A Treatment for mother liquid obtained in preparation of high-purity triethylenediamine |
| 12/18/2002 | CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine |
| 12/18/2002 | CN1096461C Purine derivatives and their use as anti-coagulants |
| 12/17/2002 | US6495700 Process for producing phenserine and its analog |
| 12/17/2002 | US6495699 Antiarthritic agents; osteoporosis |
| 12/17/2002 | US6495688 Used as corticotropin-releasing factor (crf) antagonists, in therapy and diagnosis of stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety |
| 12/17/2002 | US6495686 Therapy for psychological disorders |
| 12/17/2002 | US6495559 For therapy of obesity |
| 12/17/2002 | US6495543 Treating or preventing melatoninergic disorders |
| 12/17/2002 | US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome |
| 12/17/2002 | US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 12/17/2002 | CA2203389C Bicyclic heterocyclic compounds for the treatment of impotence |
| 12/12/2002 | WO2002098956A1 Monomers having rotaxane structure and polymers and processes for production of both |
| 12/12/2002 | WO2002098882A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 12/12/2002 | WO2002098881A1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative |
| 12/12/2002 | WO2002098880A1 5-ethyl-imidazotriazinones |
| 12/12/2002 | WO2002098879A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
| 12/12/2002 | WO2002098877A1 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 12/12/2002 | WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/12/2002 | WO2002098868A1 Epothilone derivatives |
| 12/12/2002 | WO2002098855A2 1,2,4-TRIAZOLO[4,3-a][1,3,5]TRIAZINE-3,5,7-SUBSTITUTED PRECURSOR, AND PROCESS, AND COMPOUNDS THEREFROM |
| 12/12/2002 | WO2002098428A1 Tetracyclic compounds as pde5-inhibitors |
| 12/12/2002 | WO2002098417A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 12/12/2002 | WO2002098350A2 Pyranoindazoles and their use for the treatment of glaucoma |
| 12/12/2002 | WO2002068389A3 Indole derivatives with inhibitor effects on phenol oxidase |
| 12/12/2002 | WO2002064080A3 Matrix metalloproteinase inhibitors |
| 12/12/2002 | US20020188136 Pesticides and herbicides |
| 12/12/2002 | US20020188119 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 12/12/2002 | US20020188111 For photodynamic therapy of a lesion; medical diagnosis; drug screening; bioavailability |
| 12/12/2002 | US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails |
| 12/12/2002 | US20020187984 Pharmaceutical uses and synthesis of diketopiperazines |
| 12/12/2002 | US20020187977 Methods for restoring cognitive function following systemic stress |
| 12/12/2002 | US20020187101 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 12/12/2002 | CA2449877A1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative |
| 12/12/2002 | CA2449316A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 12/12/2002 | CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/12/2002 | CA2449097A1 5-ethyl-imidazotriazinones |
| 12/12/2002 | CA2449095A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
| 12/12/2002 | CA2449077A1 Epothilone derivatives |
| 12/12/2002 | CA2447480A1 Pyranoindazoles and their use for the treatment of glaucoma |
| 12/11/2002 | EP1264836A1 Processes for the preparation of indolopyrrolocarbazole derivatives |
| 12/11/2002 | EP1263761A2 Compounds for pdt |
| 12/11/2002 | EP1263759A2 Azaindoles |